School of Medicine
Showing 241-250 of 262 Results
-
Vanessa Gulla, MD
Clinical Assistant Professor, Urology
BioDr. Gulla is a board-certified urologist with fellowship training in endourology. She is a clinical assistant professor in the Stanford University School of Medicine Department of Urology.
For each patient, she develops a comprehensive, compassionate care plan customized to individual needs. Her goal is to help each patient achieve the best possible health and quality of life.
Dr. Gulla performs the complete spectrum of diagnostic and treatment procedures for urological conditions. She treats disorders including benign prostatic hyperplasia (BPH), blood in urine, kidney stones, male and female voiding dysfunction, neurogenic bladder, prostate cancer, and over active bladder.
She excels at ureteroscopy and cystoscopy (examination of the bladder and urinary tract with a scope), endourology (minimally invasive treatment of kidney stones), laser therapy, ultrasound-guided diagnosis and treatment, urodynamic testing, and other techniques.
To help advance her field, Dr. Gulla has conducted research. Among the topics she has investigated are voiding cystourethrogram (VCUG) testing in children for bladder and urethral abnormalities and for conditions that can lead to kidney infections.
She has presented her research findings at the national meeting of the American Urologic Association. She also has published papers in the Journal of the American College of Surgeons and elsewhere.
She is a member of the American Urologic Association. -
Ruwan Gunaratne
Instructor, Medicine - Hematology
BioRuwan Gunaratne, MD, PhD is an Instructor in Hematology at Stanford University School of Medicine and a board-certified hematologist-oncologist with a clinical focus on acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPNs). His clinical and translational research centers on improving disease monitoring in myeloid cancers using personalized circulating tumor DNA (ctDNA) profiling, a blood-based approach designed to more sensitively track measurable residual disease (MRD), assess treatment response, refine risk stratification, and detect relapse earlier across the myeloid disease spectrum. Dr. Gunaratne’s work has been recognized with awards from the American Society of Hematology and the Stanford Cancer Institute, and he is actively committed to advancing precision medicine approaches for patients with myeloid malignancies.
-
Matthew Gunther, MD, MA
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
Clinical Associate Professor (By courtesy), Medicine - Primary Care and Population HealthCurrent Research and Scholarly InterestsDr. Gunther’s scholarly work focuses on improving psychiatric care for medically complex patients through integrated behavioral health, medical education, and consultation-liaison psychiatry, with particular emphasis on psychiatry-led education for internal medicine residents, psychiatric interviewing, trauma-informed communication, delirium, catatonia, and psychopharmacology in the medically ill.
-
H. Henry Guo, MD, PhD
Clinical Professor, Radiology
Current Research and Scholarly InterestsQuantitative CT
AI assisted radiology interpretation
PET imaging of lung diseases
CT imaging biomarkers heart and lung diseases
Quality assurance of ultralow dose CT scans
Post radiation treatment changes of lung tumors
3D printing -
Mengni Guo
Clinical Assistant Professor, Medicine - Oncology
BioDr. Mengni Guo is a medical oncologist in the Division of Oncology at Stanford University School of Medicine and a member of the Stanford Breast Cancer Program. She specializes in the care of patients with breast cancer, from active treatment through long-term survivorship. Dr. Guo emphasizes an individualized, team-based approach, working closely with patients and multidisciplinary specialists to develop treatment plans that reflect each patient’s clinical needs, personal values, and long-term quality of life.
Dr. Guo’s research focuses on breast cancer survivorship, particularly metabolic health during and after cancer treatment and the prevention and management of long-term treatment effects. She also uses large real-world datasets to study breast cancer treatment patterns and outcomes and to identify strategies to improve long-term health after cancer therapy. Her research has been presented at national meetings, including the American Society of Clinical Oncology (ASCO) Annual Meeting.
